A randomized double-blind multi-center trial of hydrogen water for Parkinson’s disease: protocol and baseline characteristics.
Asako Yoritaka, Takashi Abe, Chigumi Ohtsuka, Tetsuya Maeda, Masaaki Hirayama, Hirohisa Watanabe, Hidemoto Saiki, Genko Oyama, Jiro Fukae, Yasushi Shimo, Taku Hatano, Sumihiro Kawajiri, Yasuyuki Okuma, Yutaka Machida, Hideto Miwa, Chikako Suzuki, Asuka Kazama, Masahiko Tomiyama, Takeshi Kihara, Motoyuki Hirasawa, Hideki Shimura, Nobutaka Hattori · BMC neurology · 2016
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
This publication is an erratum or correction associated with a molecular-hydrogen article. It does not report a new standalone experiment.
What This Publication Is
This record is an erratum, correction, or corrigendum associated with an earlier publication.
What Readers Should Review
Read the correction together with the original publication so the amended information is interpreted in context.